Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,272 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Improved diagnostic accuracy with three lung tumor markers compared to six-marker panel.
Izawa A, Hara Y, Horita N, Muraoka S, Kaneko M, Kaneko A, Somekawa K, Hirata M, Otsu Y, Matsumoto H, Nagasawa R, Tanaka K, Kubo S, Murohashi K, Aoki A, Fujii H, Watanabe K, Kobayashi N, Miura K, Nakajima H, Kaneko T. Izawa A, et al. Among authors: kubo s. Transl Lung Cancer Res. 2024 Mar 29;13(3):503-511. doi: 10.21037/tlcr-23-855. Epub 2024 Mar 15. Transl Lung Cancer Res. 2024. PMID: 38601457 Free PMC article.
Afatinib + bevacizumab combination therapy in EGFR-mutant NSCLC patients with osimertinib resistance: Protocol of an open-label, phase II, multicenter, single-arm trial.
Kobayashi N, Hashimoto H, Kamimaki C, Nagasawa R, Tanaka K, Kubo S, Katakura S, Chen H, Hirama N, Ushio R, Aoki A, Nakashima K, Teranishi S, Manabe S, Watanabe H, Horita N, Watanabe K, Hara Y, Yamamoto M, Kudo M, Piao H, Kaneko T. Kobayashi N, et al. Among authors: kubo s. Thorac Cancer. 2020 Aug;11(8):2125-2129. doi: 10.1111/1759-7714.13503. Epub 2020 Jun 3. Thorac Cancer. 2020. PMID: 32495514 Free PMC article. Clinical Trial.
MicroRNA-200b is a potential biomarker of the expression of PD-L1 in patients with lung cancer.
Katakura S, Kobayashi N, Hashimoto H, Kamimaki C, Tanaka K, Kubo S, Nakashima K, Teranishi S, Manabe S, Watanabe K, Horita N, Hara Y, Yamamoto M, Kudo M, Piao H, Kaneko T. Katakura S, et al. Among authors: kubo s. Thorac Cancer. 2020 Oct;11(10):2975-2982. doi: 10.1111/1759-7714.13653. Epub 2020 Sep 7. Thorac Cancer. 2020. PMID: 32893980 Free PMC article.
Identification of a novel biomarker based on lymphocyte count, albumin level, and TBAg/PHA ratio for differentiation between active and latent tuberculosis infection in Japan.
Katakura S, Kobayashi N, Hashimoto H, Kamimaki C, Tanaka K, Kubo S, Nakashima K, Teranishi S, Watanabe K, Hara Y, Yamamoto M, Kudo M, Piao H, Kaneko T. Katakura S, et al. Among authors: kubo s. Tuberculosis (Edinb). 2020 Dec;125:101992. doi: 10.1016/j.tube.2020.101992. Epub 2020 Sep 11. Tuberculosis (Edinb). 2020. PMID: 32957053
T-cell response to phytohemagglutinin in the interferon-γ release assay as a potential biomarker for the response to immune checkpoint inhibitors in patients with non-small cell lung cancer.
Kamimaki C, Kobayashi N, Hirata M, Somekawa K, Fukuda N, Kubo S, Katakura S, Teranishi S, Watanabe K, Horita N, Hara Y, Yamamoto M, Kudo M, Piao H, Kaneko T. Kamimaki C, et al. Among authors: kubo s. Thorac Cancer. 2021 Jun;12(11):1726-1734. doi: 10.1111/1759-7714.13978. Epub 2021 May 4. Thorac Cancer. 2021. PMID: 33943031 Free PMC article.
Identification of serum prognostic biomarkers of severe COVID-19 using a quantitative proteomic approach.
Kimura Y, Nakai Y, Shin J, Hara M, Takeda Y, Kubo S, Jeremiah SS, Ino Y, Akiyama T, Moriyama K, Sakai K, Saji R, Nishii M, Kitamura H, Murohashi K, Yamamoto K, Kaneko T, Takeuchi I, Hagiwara E, Ogura T, Hasegawa H, Tamura T, Yamanaka T, Ryo A. Kimura Y, et al. Among authors: kubo s. Sci Rep. 2021 Oct 19;11(1):20638. doi: 10.1038/s41598-021-98253-9. Sci Rep. 2021. PMID: 34667241 Free PMC article.
2,272 results